During this webinar, learners can expect to receive review and panel discussion on advances/latest practice-changing data surrounding the most recent developments and emerging novel therapies for GvHD (including, but not limited to, the current treatment landscape, strategies in GvHD prophylaxis, and emerging therapies for patients with aGvHD and cGvHD). The selected format for this program features peer-to-peer discussion and direct expert faculty interaction with the audience. In addition, expert faculty will provide webinar attendees with a comprehensive understanding of practical approaches to patient management that will enhance their ability to integrate insights upon their return to the clinic. Each portion of the program will include a case review and didactic presentation by an expert faculty member followed by a moderated panel discussion and audience Q&A session. Faculty will discuss key clinical questions, available evidence, and challenges that affect clinical decisions as well as their individual management recommendations for each case. Throughout the program, learners will be able to vote on case scenarios and directly submit questions to the panel for their consideration. Discussion topics will include:

• Updates in Diagnostic and Prognostic Biomarkers in GvHD
• Optimizing Prophylaxis Strategies for GvHD
• Recent Advances in aGvHD and cGvHD Therapy